SLP

Simulations Plus
NASDAQ

Real-time Quotes | Nasdaq Last Sale

35.60
-0.84
-2.31%
After Hours: 35.60 0 0.00% 16:00 02/27 EST
OPEN
36.00
PREV CLOSE
36.44
HIGH
37.57
LOW
33.57
VOLUME
309.80K
TURNOVER
--
52 WEEK HIGH
41.95
52 WEEK LOW
19.74
MARKET CAP
628.10M
P/E (TTM)
70.94
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of SLP and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average SLP stock price target is 39.50 with a high estimate of 40.00 and a low estimate of 39.00.

EPS

SLP News

More
  • Can Simulations Plus, Inc.'s (NASDAQ:SLP) ROE Continue To Surpass The Industry Average?
  • Simply Wall St. · 1d ago
  • 2 Multi-Bagger High-Growth Strategies, 1 For Retirees
  • Seeking Alpha - Article · 02/15 14:23
  • DILIsym Services Partners with Large Pharmaceutical Company to Begin QSP Model Development for Heart Failure
  • Business Wire · 02/04 13:30
  • 2 Growing Healthcare Stocks You Should Know
  • MotleyFool.com · 01/22 15:30

Industry

Advanced Medical Equipment & Technology
-3.12%
Healthcare Equipment & Supplies
-2.75%

Hot Stocks

Symbol
Price
%Change
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%

About SLP

Simulations Plus, Inc. (Simulations Plus) develops and produces software for use in pharmaceutical research and for education, and provides consulting and contract research services to the pharmaceutical industry. The Company offers five software products for pharmaceutical research. ADMET (Absorption, Distribution, Metabolism, Excretion and Toxicity) Predictor is a computer program that takes molecular structures as inputs and predicts over 140 different properties for them at the rate of about 200,000 compounds per hour. MedChem Designer includes a small set of ADMET Predictor property predictions, allowing the chemist to modify molecular structures. MedChem Studio is a tool for medicinal and computational chemists for both data mining and for designing new drug-like molecules. DDDPlus simulates in-vitro laboratory experiments used to measure the rate of dissolution of the drug. GastroPlus simulates the absorption, pharmacokinetics, and pharmacodynamics of drugs.
More

Webull offers kinds of Simulations Plus, Inc. stock information, including NASDAQ:SLP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SLP stock news, and many more online research tools to help you make informed decisions.